A new era of the Asian clinical research network: a report from the ATLAS international symposium
Issued Date
2023-06-29
Resource Type
eISSN
14653621
Scopus ID
2-s2.0-85164232909
Pubmed ID
37099440
Journal Title
Japanese journal of clinical oncology
Volume
53
Issue
7
Start Page
619
End Page
628
Rights Holder(s)
SCOPUS
Bibliographic Citation
Japanese journal of clinical oncology Vol.53 No.7 (2023) , 619-628
Suggested Citation
Terada M., Nakamura K., Matsuda T., Okuma H.S., Sudo K., Yusof A., Imasa M., Sirachainan E., Anh P.T., Fujiwara Y., Yamamoto N., Voon P.J., Chokephaibulkit K., Shibata T., Inoue M., Mano H., Shimoi T., Sriuranpong V., Yonemori K., Shimada K. A new era of the Asian clinical research network: a report from the ATLAS international symposium. Japanese journal of clinical oncology Vol.53 No.7 (2023) , 619-628. 628. doi:10.1093/jjco/hyad033 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/87949
Title
A new era of the Asian clinical research network: a report from the ATLAS international symposium
Author's Affiliation
Ramathibodi Hospital
Siriraj Hospital
Hospital Umum Sarawak
St. Luke's Medical Center Quezon City
Pharmaceuticals and Medical Devices Agency
National Cancer Center Research Institute
National Cancer Center Japan
National Cancer Center Hospital
Faculty of Medicine, Chulalongkorn University
Thai Society of Clinical Oncology
Malaysia
Vietnam National Cancer Hospital
Siriraj Hospital
Hospital Umum Sarawak
St. Luke's Medical Center Quezon City
Pharmaceuticals and Medical Devices Agency
National Cancer Center Research Institute
National Cancer Center Japan
National Cancer Center Hospital
Faculty of Medicine, Chulalongkorn University
Thai Society of Clinical Oncology
Malaysia
Vietnam National Cancer Hospital
Other Contributor(s)
Abstract
This report summarizes the presentations and discussions in the first Asian Clinical Trials Network for Cancers (ATLAS) international symposium that was held on 24 April 2022, in Bangkok, Thailand, and hosted by the National Cancer Center Hospital (NCCH), co-hosted by the Pharmaceuticals and Medical Devices Agency (PMDA), Clinical Research Malaysia (CRM) and the Thai Society of Clinical Oncology (TSCO), and supported by Embassy of Japan in Thailand. Since 2020, the NCCH has conducted the ATLAS project to enhance research environments and infrastructures to facilitate international clinical research and cancer genomic medicine in the Asian region. The purpose of the symposium was to discuss what we can achieve under the ATLAS project, to share the latest topics and common issues in cancer research and to facilitate mutual understanding. Invitees included stakeholders from academic institutions, mainly at ATLAS collaborative sites, as well as Asian regulatory authorities. The invited speakers discussed ongoing collaborative research, regulatory perspectives to improve new drug access in Asia, the status of phase I trials in Asia, the introduction of research activities at the National Cancer Center (NCC) and the implementation of genomic medicine. As the next steps after this symposium, the ATLAS project will foster increased cooperation between investigators, regulatory authorities and other stakeholders relevant to cancer research, and establish a sustainable pan-Asian cancer research group to increase the number of clinical trials and deliver novel drugs to patients with cancer in Asia.